Author Question: If the firms in a monopolistically competitive industry are suffering short-run losses, which of the ... (Read 28 times)

renzo156

  • Hero Member
  • *****
  • Posts: 526
If the firms in a monopolistically competitive industry are suffering short-run losses, which of the following will occur in the long run?
 a. Some firms will enter the industry.
  b. Customers of firms that leave the industry will switch to remaining firms.
  c. Firms that remain in the industry will face reduced demand.
  d. Firms will continue to incur losses.
  e. There will be no excess capacity.

Question 2

Because information and the time required to acquire and digest it are scarce,
 a. consumers concentrate on private choices rather than on public choices
  b. consumers concentrate on public choices rather than on private choices
  c. it is irrational for consumers to remain ignorant of the costs and benefits of government proposals
  d. consumers have greater incentive to gather and act upon information about public choices than to gather and act upon information about their private choices
  e. an individual voter has more incentive to examine the performance records of candidates for public office



asware1

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

B

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library